| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $117.51 | $24.80 | 373.88% | 221.71x | 55.92x | 14.90x | 18.00x | 1.61x | $106.92M | 0.86% | $705.78M | 6.70 | $12.60B | 1,606.18 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.78 | $8.47 | 227.93% | 132.29x | 62.11x | 7.81x | 15.83x | 1.13x | $39.15M | 1.08% | $220.58M | 1.69 | $3.57B | 78.68 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $251.65 | $83.00 | 203.20% | 41.25x | 37.32x | 7.00x | 24.87x | 1.42x | $793.95M | 2.36% | $1.35B | 10.14 | $34.95B | 29.64 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.00 | $17.86 | 336.62% | 72.90x | 66.73x | 7.20x | 9.30x | 1.86x | $182.84M | 3.02% | $654.15M | 8.43 | $5.92B | 49.34 | ||
| HALO | HALOZYME THERAPEUTICS INC | $115.13 | $73.40 | 56.86% | 32.34x | 12.75x | 8.12x | 91.03x | 0.62x | $806.22M | 5.97% | $143.54M | 1.22 | $15.05B | 20.95 | ||
| KRYS | KRYSTAL BIOTECH INC | $350.88 | $86.60 | 305.16% | 42.43x | 44.95x | 23.52x | 7.64x | 2.27x | $257.78M | 2.49% | $1.36B | 46.03 | $9.97B | 42.72 | ||
| VCEL | VERICEL CORP | $40.22 | $8.25 | 387.73% | 83.79x | 71.86x | 6.71x | 5.57x | 2.06x | $61.66M | 3.00% | $370.04M | 7.25 | $2.03B | 46.01 | ||
| RPRX | ROYALTY PHARMA PLC | $58.52 | $37.32 | 56.82% | 31.13x | 10.70x | 10.27x | 3.44x | 0.63x | $2.92B | 11.23% | $9.79B | 21.99 | $41.80B | 35.54 | ||
| TGTX | TG THERAPEUTICS INC | $58.11 | $23.12 | 151.29% | 18.87x | 58.47x | 10.30x | 14.72x | 2.10x | $17.39M | 0.21% | $604.08M | 4.26 | $9.16B | 65.82 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $63.37 | $19.22 | 229.70% | 166.76x | 21.90x | 3.60x | 1.94x | 1.11x | $738.18M | 6.02% | $6.32B | 32.68 | $15.58B | 40.39 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.58 | $7.85 | 47.51% | 12.19x | 10.64x | 5.03x | 3.16x | 1.06x | $82.01M | 11.97% | $217.65M | 3.68 | $543.84M | 7.03 | ||
| ADMA | ADMA BIOLOGICS INC | $9.81 | $7.20 | 36.30% | 13.63x | 12.33x | 4.37x | 5.38x | 0.79x | $116.47M | 5.20% | $408.21M | 1.79 | $2.26B | 9.70 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $240.57 | $185.94 | 29.38% | 15.76x | 9.41x | 3.30x | 3.25x | 0.65x | $1.62B | 10.65% | $4.80B | 75.98 | $18.39B | 11.38 | ||
| EXEL | EXELIXIS INC | $58.15 | $30.95 | 87.89% | 17.67x | 17.58x | 5.99x | 7.81x | 1.16x | $1.17B | 8.04% | $1.84B | 7.35 | $14.29B | 13.14 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $298.50 | $88.55 | 237.08% | 29.64x | 31.60x | 20.61x | 6.15x | 2.25x | $130.62M | 2.18% | $967.52M | 48.22 | $6.08B | 21.78 | ||
| MDXG | MIMEDX GROUP INC | $4.93 | $1.31 | 275.42% | 123.25x | -28.43x | 2.05x | 3.33x | 1.34x | $44.50M | 6.11% | $216.00M | 1.46 | $599.97M | 26.30 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $514.99 | $153.04 | 236.51% | 29.72x | 26.90x | 10.38x | 6.45x | 2.23x | $3.80B | 2.91% | $20.25B | 79.81 | $126.36B | 22.96 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.53 | $31.04 | 33.79% | 13.23x | 9.96x | 2.51x | 2.42x | 0.79x | $354.90M | 14.75% | $999.24M | 17.25 | $2.02B | 7.22 | ||
| UTHR | UNITED THERAPEUTICS CORP | $497.59 | $194.56 | 155.75% | 16.45x | 18.62x | 6.72x | 3.33x | 3.02x | $1.09B | 5.16% | $6.40B | 150.24 | $19.54B | 11.65 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $803.90 | $441.38 | 82.13% | 19.17x | 14.33x | 5.32x | 2.61x | 1.01x | $3.76B | 4.55% | $31.71B | 308.48 | $83.02B | 14.44 | ||
| TECH | BIO-TECHNE CORP | $72.55 | $16.80 | 331.94% | 62.01x | 34.92x | 9.31x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.79 | ||
| VCYT | VERACYTE INC | $43.36 | $12.10 | 258.44% | 30.11x | 22.29x | 6.17x | 2.51x | 2.53x | $165.99M | 4.79% | $1.39B | 17.36 | $3.22B | 23.09 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.36 | $1.43 | -5.01% | 9.71x | -3.07x | 1.68x | 1.79x | 0.54x | $19.58M | 24.85% | $44.20M | 0.76 | $30.47M | 3.99 | ||
| INCY | INCYTE CORP | $126.93 | $60.76 | 108.89% | 15.63x | 35.80x | 4.37x | 4.06x | 1.76x | $1.92B | 7.55% | $6.34B | 31.66 | $21.78B | 10.53 |